Clinical implication of ZEB-1 and E-cadherin expression in hepatocellular carcinoma (HCC)

@inproceedings{Hashiguchi2013ClinicalIO,
  title={Clinical implication of ZEB-1 and E-cadherin expression in hepatocellular carcinoma (HCC)},
  author={Motoyuki Hashiguchi and Shinichi Ueno and Masahiko Sakoda and Satoshi Iino and Kiyokazu Hiwatashi and Koji Minami and Kei Ando and Yuko Mataki and Kosei Maemura and Hiroyuki Shinchi and Sumiya Ishigami and Shoji Natsugoe},
  booktitle={BMC Cancer},
  year={2013}
}
While recent research has shown that expression of ZEB-1 in a variety of tumors has a crucial impact on patient survival, there is little information regarding ZEB-1 expression in hepatocellular carcinoma (HCC). This study investigated the co-expression of ZEB-1 and E-cadherin in HCC by immunohistochemistry and evaluated its association with clinical factors, including patient prognosis. A total of 108 patients with primary HCC treated by curative hepatectomy were enrolled. ZEB-1 expression was… CONTINUE READING
22 Citations
30 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 22 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 30 references

Clinicopathological significance of ZEB1 protein in patients with hepatocellular carcinoma

  • YM Zhou, L Cao, +4 authors JM Yang
  • Ann Surg Oncol
  • 2012
Highly Influential
3 Excerpts

Similar Papers

Loading similar papers…